Switzerland-based specialty chemicals group Clariant has unveiled a plan to expand its facility in Lewiston, Maine, US.

Under the expansion, a new compounding line will be installed to help meet the increasing demand for Clariant’s pre-coloured medical plastic compounds, which the company provides for medical devices and pharmaceutical packaging applications.

Go deeper with GlobalData

Data Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Scheduled to become operational by late 2017, the planned compounding line will be built around a new 70mm extruder.

Once commissioned, the line will be able to produce large batches of pre-coloured medical plastic compounds, such as polyolefins, ABS, PC and PC alloys, as well as specialty resins.

In addition, the Lewiston site will be expanded to improve its procedures and material-handling.

"Over the last five years, Clariant has pioneered the development of masterbatches for the healthcare sector."

Clariant global segment healthcare polymer solutions head Steve Duckworth said: “Over the last five years, Clariant has pioneered the development of masterbatches for the healthcare sector.

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

“These are colour and additive concentrates that are added to natural polymers during moulding or extrusion of finished products.

“However, in some cases, medical processors may prefer to use a pre-coloured compound instead, perhaps for ease of handling or because of technical difficulties in the moulding or extrusion process. And yet, they have the same need for controlled, consistent and compliant materials.”

The company’s Lewiston plant is one of three sites, which are designed and operated to produce materials used in medical devices and pharmaceutical packaging.

The other two facilities are situated in Malmö, Sweden, and Singapore.

These three sites are currently producing masterbatches and pre-coloured compounds in various sizes, ranging from 25kg to 2,500kg.